ArticleActa neurochirurgica2026
Endoscopic endonasal transsphenoidal management of an indirect cavernous sinus dural arteriovenous fistula: a case report.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cavernous sinus dural arteriovenous fistula (CS-DAVF) is a rare vascular disorder, with clinical manifestations largely determined by venous drainage patterns. Conventional endovascular treatment via the inferior petrosal sinus or superior ophthalmic vein may be unsuccessful when these access routes are occluded. We report a case of an CS-DAVF (Barrow type D) in which two prior endovascular attempts failed, and complete obliteration of the fistula was subsequently achieved through direct puncture of the cavernous sinus under endoscopic endonasal guidance. Postoperatively, the patient experienced complete resolution of pulsatile tinnitus and stabilization of ocular function. This case suggests that the endoscopic endonasal approach may represent a safe and effective alternative for carefully selected indirect CS-DAVF patients when standard endovascular access is not feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.